Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs PFIZER - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA PFIZER ABBOTT INDIA/
PFIZER
 
P/E (TTM) x 48.6 47.0 103.3% View Chart
P/BV x 15.9 7.8 204.2% View Chart
Dividend Yield % 0.4 0.4 98.5%  

Financials

 ABBOTT INDIA   PFIZER
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
PFIZER
Mar-19
ABBOTT INDIA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs8,8343,840 230.1%   
Low Rs5,4582,080 262.4%   
Sales per share (Unadj.) Rs1,731.1455.0 380.5%  
Earnings per share (Unadj.) Rs211.993.8 226.0%  
Cash flow per share (Unadj.) Rs219.9109.4 201.0%  
Dividends per share (Unadj.) Rs65.0022.50 288.9%  
Dividend yield (eoy) %0.90.8 119.7%  
Book value per share (Unadj.) Rs945.2658.2 143.6%  
Shares outstanding (eoy) m21.2545.75 46.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.16.5 63.4%   
Avg P/E ratio x33.731.6 106.8%  
P/CF ratio (eoy) x32.527.1 120.1%  
Price / Book Value ratio x7.64.5 168.1%  
Dividend payout %30.724.0 127.8%   
Avg Mkt Cap Rs m151,848135,420 112.1%   
No. of employees `0003.52.6 132.5%   
Total wages/salary Rs m4,3563,238 134.5%   
Avg. sales/employee Rs Th10,555.57,911.4 133.4%   
Avg. wages/employee Rs Th1,249.91,230.9 101.5%   
Avg. net profit/employee Rs Th1,292.21,630.7 79.2%   
INCOME DATA
Net Sales Rs m36,78620,815 176.7%  
Other income Rs m1,1331,674 67.7%   
Total revenues Rs m37,91922,489 168.6%   
Gross profit Rs m6,0475,712 105.9%  
Depreciation Rs m169714 23.7%   
Interest Rs m2373 30.9%   
Profit before tax Rs m6,9896,599 105.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,4852,309 107.6%   
Profit after tax Rs m4,5034,291 105.0%  
Gross profit margin %16.427.4 59.9%  
Effective tax rate %35.635.0 101.7%   
Net profit margin %12.220.6 59.4%  
BALANCE SHEET DATA
Current assets Rs m27,61027,167 101.6%   
Current liabilities Rs m8,5698,917 96.1%   
Net working cap to sales %51.887.7 59.0%  
Current ratio x3.23.0 105.8%  
Inventory Days Days6068 88.8%  
Debtors Days Days2730 91.0%  
Net fixed assets Rs m1,0578,862 11.9%   
Share capital Rs m213458 46.4%   
"Free" reserves Rs m19,87329,656 67.0%   
Net worth Rs m20,08630,113 66.7%   
Long term debt Rs m025 0.0%   
Total assets Rs m29,40939,400 74.6%  
Interest coverage x311.691.5 340.5%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.5 236.8%   
Return on assets %15.411.1 139.0%  
Return on equity %22.414.2 157.4%  
Return on capital %34.922.1 157.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m369428 86.1%   
Fx outflow Rs m4,918786 625.4%   
Net fx Rs m-4,549-358 1,270.4%   
CASH FLOW
From Operations Rs m4,991978 510.3%  
From Investments Rs m-2,570351 -731.8%  
From Financial Activity Rs m-1,428-1,099 130.0%  
Net Cashflow Rs m993231 430.4%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 63.9 117.4%  
Indian inst/Mut Fund % 7.9 7.5 105.3%  
FIIs % 0.1 4.9 2.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 23.7 72.2%  
Shareholders   18,270 85,207 21.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   ELDER PHARMA  FDC  SUN PHARMA  DISHMAN PHARMA  TTK HEALTHCARE  

Compare ABBOTT INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Momentum Moves: The Week Gone By(Momentum Moves)

Nifty and Sensex ended the week gaining 0.60% and 0.52% respectively. Bulls started the week roaring but since Wednesday, the momentum seemed to be tiring.

Related Views on News

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY21); Net Profit Up 10.3% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, PFIZER has posted a net profit of Rs 1 bn (up 10.3% YoY). Sales on the other hand came in at Rs 5 bn (down 5.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Five Wishes and a Will(The Honest Truth)

Jan 4, 2021

Ajit Dayal on the investing strategy for 2021 and beyond.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jan 15, 2021 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS